Statements (18)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:CEO |
Chris Nowers
|
| gptkbp:collaboratesWith |
gptkb:National_University_of_Ireland_Galway
|
| gptkbp:developedBy |
off-the-shelf NK cell therapies
|
| gptkbp:focusesOn |
immunotherapy
natural killer cell therapies |
| gptkbp:foundedIn |
2015
|
| gptkbp:founder |
Liam Daniel
|
| gptkbp:headquartersLocation |
gptkb:Galway,_Ireland
|
| https://www.w3.org/2000/01/rdf-schema#label |
ONK Therapeutics
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:technology |
CAR-NK cell engineering
CISH knockout NK cells |
| gptkbp:therapeuticArea |
solid tumors
hematological malignancies |
| gptkbp:website |
https://www.onktherapeutics.com/
|
| gptkbp:bfsParent |
gptkb:Fate_Therapeutics
|
| gptkbp:bfsLayer |
7
|